
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
The Long Run with Luke Timmerman
00:00
Is This a Place Where Company Builders Are Made?
You got one point eight billion dollars. Is this a place where company builders are made? I just think it's following the science, a list riht, and following the clinical or kind of market need. You know, clinical trials need to be reinvented. Manufacturing is ge issue. Am, you know, we think the frontiers of science will go into a kind of a invvo gen therapy and invivo potentiation of cell state,. rejuvenation of cells, organs people, things like that.
Transcript
Play full episode